Trial intelligence / Profile preview

Phase 3 trial of 5% minoxidil foam versus 2% minoxidil solution in women with female pattern hair loss

2009-018109-29Phase 3Completed

Sponsor
Johnson & Johnson
Start
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of minoxidil in androgenetic alopecia (AGA) (2 arms), sponsored by Johnson & Johnson. Started Apr 2010; status: completed.

02

Drugs

minoxidil
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on 2009-018109-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-018109-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call